Fca Corp Gsk PLC Transaction History

Fca Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $289,595 - $339,490	8,500 New	8,500 $313,000
Q3 2020 Nov 12, 2020	SELL	$38.11 - $42.99 $323,935 - $365,415	-8,500 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $78,800 - $85,400	2,000 Added 30.77%	8,500 $340,000
Q3 2017 Nov 09, 2017	BUY	$39.44 - $41.55 $256,359 - $270,075	6,500	6,500 $264,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Fca Corp , based on Form 13F filings with the SEC.

Stay updated on Fca Corp with notifications on news.